15-90887322-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002005.4(FES):c.620G>A(p.Gly207Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,613,058 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002005.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FES | NM_002005.4 | c.620G>A | p.Gly207Asp | missense_variant | 5/19 | ENST00000328850.8 | NP_001996.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FES | ENST00000328850.8 | c.620G>A | p.Gly207Asp | missense_variant | 5/19 | 1 | NM_002005.4 | ENSP00000331504.3 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152256Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000128 AC: 32AN: 249380Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135364
GnomAD4 exome AF: 0.000142 AC: 207AN: 1460684Hom.: 1 Cov.: 55 AF XY: 0.000162 AC XY: 118AN XY: 726666
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152374Hom.: 0 Cov.: 34 AF XY: 0.0000939 AC XY: 7AN XY: 74524
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.620G>A (p.G207D) alteration is located in exon 5 (coding exon 4) of the FES gene. This alteration results from a G to A substitution at nucleotide position 620, causing the glycine (G) at amino acid position 207 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at